Company news

Cardiol Therapeutics Inc. news in 2023

Cardiol Therapeutics Inc.'s news releases, calls and decks from 2023, newest first.

View company

Cardiol Therapeutics Announces Massachusetts General Hospital, Largest Teaching Hospital of Harvard Medical School, as the 8th Major Medical Centre Participating in MAvERIC-Pilot

December 5, 2023

Cardiol Therapeutics Announces Study Results Presented at the 2023 Annual Meeting of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases

November 16, 2023

Cardiol Therapeutics Announces It Has Exceeded 50% Enrollment in Its Phase II MAvERIC-Pilot Study in Recurrent Pericarditis

November 1, 2023

Cardiol Therapeutics Receives Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement

October 20, 2023

Cardiol Therapeutics (NASDAQ: CRDL) Advancements in Therapies for Inflammatory Heart Diseases

October 13, 2023

Cardiol Therapeutics releases positive study results of subcutaneously administered cannabidiol

October 11, 2023

Cardiol Therapeutics Announces Positive Study Results Demonstrating Cardioprotective Effects of Subcutaneously Administered Cannabidiol in a Model of Heart Failure with Preserved Ejection Fraction

October 10, 2023

Cardiol Therapeutics to Present at Cantor Fitzgerald 2023 Global Healthcare Conference

September 26, 2023

Cardiol Therapeutics Announces All Collaborating Clinical Research Centers Now Initiated and Eligible to Enroll Patients in ARCHER, a Phase II Trial of CardiolRx(TM) for the Treatment of Acute Myocarditis

September 19, 2023

Cardiol Therapeutics to Present at Canaccord Genuity 43rd Annual Growth Conference

August 9, 2023

Cardiol Therapeutics Reports Results of 2023 Annual General Meeting

June 29, 2023

Cardiol Therapeutics to Webcast Virtual Annual General Meeting on June 28th at 4: 30 p.m. EDT

June 27, 2023

Cardiol Therapeutics Announces Year-End 2022 Update on Operations

March 29, 2023

Cardiol Therapeutics Announces Study Results from Collaborating Research Center Demonstrating Cardioprotective Effects of Cannabidiol in a Model of Heart Failure

March 7, 2023

Cardiol Therapeutics says first patient enrolled in Phase 2 study of CardiolRx for Pericarditis

January 17, 2023

Cardiol Therapeutics Announces First Patient Enrolled in Phase II Study Evaluating CardiolRx(TM) for the Treatment of Recurrent Pericarditis

January 17, 2023

Decks in 2023